patent.fyi
Applications  /  US 2026/0354715
United States Patent Application Publication

US 2026/0354715 A1

Published
Nov 12, 2026
Filed
Jun 19, 2026
Earliest date on the face
Dec 20, 2023
Classification
A61B 5/14546
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Surface sampling through intact skin

What ifWhat if the sensor stays on the intact skin surface and measures glucose extracted into a collection gel?
Claim language“inserted into the body tissue”

A pair of skin-contact electrodes applies a low current to draw glucose into a hydrated gel by reverse iontophoresis. A glucose oxidase electrode in the gel measures the extracted glucose during successive sampling cycles.

1.2Solid blade guides insertion

What ifWhat if a solid blade carries the sensor filament along its outer face during insertion?
Claim language“an insertion cannula”

A sharpened stainless steel blade opens a path in the skin while an actuator advances the sensor filament alongside it. A spring retracts the blade while a skin-mounted sensor base holds the filament at the insertion depth.

1.3Peel pouch encloses assembly

What ifWhat if a heat-sealed peel pouch encloses the entire assembly until use?
Claim language“a removable sterility cap”

A porous sheet and a polymer film form the pouch and admit sterilant gas through the porous sheet during processing. The perimeter seal maintains the sterile barrier during storage, and the user peels the two sheets apart to release the assembly before insertion.

1.4Closed bore guides insertion

What ifWhat if the sensor and insertion assembly travel through a cylindrical bore with a continuous sidewall?
Claim language“an open channel”

A molded cylindrical sleeve surrounds the insertion assembly along its travel path. A sliding cannula holder enters through one axial end and guides the cannula and sensor through the other end.

1.4Flat flanges weld directly

What ifWhat if a direct weld between flat perimeter flanges seals the housing?
Claim language“a sealing channel”

A fixture clamps the thermoplastic flanges together as a laser scans the joint through the upper flange. The lower flange absorbs the beam, and the polymer at the interface melts and cools into a continuous seam.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Interstitial glucose monitoring in dairy cattle

A flexible electrochemical glucose sensor sits partly inside a slotted insertion cannula attached to a retractable holder. A removable cap closes the skin-facing end of the open housing channel, and the holder closes the opposite end to form the sterile compartment. A two-piece housing contains the readout electronics, and a sealing channel with inlet and outlet ports carries sealant along the housing joint. A veterinary operator removes the cap, places the housing on clipped flank skin, and advances and retracts the cannula to leave the sensor in subcutaneous tissue.

Component substitution

Fluorescence lifetime glucose sensing filament

A fiber-optic filament replaces the electrochemical sensing strip and carries a glucose-responsive boronic acid fluorophore immobilized in a permeable hydrogel at its tip. The filament sits partly inside a slotted cannula, and the removable cap, open housing channel, and cannula holder enclose the sterile insertion region. A sealed optical feedthrough couples the filament to a pulsed light-emitting diode and a filtered photodiode in the electronics compartment, and sealant fills the ported housing channel. After cannula withdrawal, the electronics measure fluorescence decay and convert the measured lifetime to glucose concentration using a temperature-indexed calibration table.

Parameter or scale variation

Fixed insertion depth and sampling interval

The housing guides a slotted cannula containing a flexible sensing strip with a 2 mm active segment at its distal end. A mechanical stop limits holder travel to place the sensor tip 5 mm below the skin-contact plane, and a return spring retracts the cannula into the housing while an anchor retains the strip at depth. The cap, open housing channel, and holder enclose the sterile insertion region before cap removal, and a separate ported sealant channel seals the housing joint. The electronics sample electrode current every 10 seconds and report the median glucose estimate from each group of six samples.

Combination with existing systems

Glucose readings at the bedside

A hospital bedside telemetry receiver pairs over a short-range radio link with the electronics in the wearable monitor. The wearable retains the capped insertion channel and the two-piece housing with a ported sealant channel, and its antenna sits inside the electronics compartment along the outer housing wall. Each packet carries a timestamp, glucose concentration, and sensor status, and the receiver forwards these values to a hospital vital-signs display under the assigned bed identifier. The display plots the readings alongside other vital signs and marks the last glucose value as stale when packets stop arriving.

Automated or data-driven variant

Optical detection of sealant arrival

An automated fixture connects a metering pump to the sealing channel inlet and fits a transparent vent tube to the outlet. An infrared emitter and photodiode face each other across the tube, and the controller detects the change in transmitted light when a filled silicone sealant reaches the outlet. The controller stops the pump and compares the delivered volume with the production limits for the housing. The removable cap and cannula holder stay seated at the ends of the open insertion channel during dispensing and curing.

Motion detection during glucose sampling

A three-axis accelerometer mounts on the sensor readout board inside the sealed electronics compartment, while the cap, open housing channel, and cannula holder enclose the sterile insertion region before deployment. The controller timestamps acceleration and sensor-current samples with the same clock and computes acceleration magnitude over each glucose reporting interval. Software adds a motion flag when acceleration exceeds a preset threshold in the same interval as a rapid change in sensor current. The monitor stores and transmits the flag alongside the glucose value for display on the receiving device.

Specific version of a part

Separate cartridge maintains sterility

A molded cartridge shell encloses the cannula and insertable sensor portion, and a peelable foil membrane seals its tissue-facing opening. A flexible diaphragm closes the actuator end and transmits plunger motion to the cannula holder after the foil is peeled.

Amperometric glucose sensor filament

A flexible polyimide filament carries a platinum working electrode, a counter electrode, and a silver–silver chloride reference electrode. A glucose oxidase layer generates peroxide from glucose in interstitial fluid, and the circuit measures peroxide oxidation current at the working electrode.

Slotted cannula with molded holder

A longitudinal slot in a stainless steel cannula receives a flexible sensor filament. A molded polymer holder grips the proximal end of the cannula and couples it to a spring-loaded retraction mechanism.

Twist release sterility cap

A rigid polymer cap covers the protruding cannula and sensor tip, and a silicone gasket seals the cap against the housing. A quarter turn releases two retaining tabs so the user can pull the cap straight off along the cannula axis.

Vented perimeter adhesive channel

A molded perimeter recess forms a sealing channel between the assembled housing halves. A dispensing nozzle injects epoxy through the input port until it appears at the output port, and the epoxy cures across the joint.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2018/0325616 A1
Published
Nov 15, 2018
Filed
Nov 13, 2015
Class
A61B 46/10
Document BUS 2019/0021636 A1
Published
Jan 24, 2019
Filed
Feb 3, 2017
Class
A61B 5/1473
Claim 1
Document A
Document B
1.1an analyte sensor configured for detecting an analyte in a body fluid of a user, the analyte sensor comprising an insertable portion adapted for at least partially being inserted into the body tissue;
In a first aspect of the present invention, a medical device for detecting at least one analyte in a body fluid is disclosed. The medical device comprises at least one analyte sensor having an insertable portion adapted for at least partially being inserted into a body tissue of a user.
B · US 2019/0021636 A1 · ¶ 20
1.2an insertion component comprising an insertion cannula and an insertion cannula holder, wherein the insertion cannula is attached to the insertion cannula holder and the analyte sensor is at least partially placed inside the insertion cannula;
The medical device further comprises at least one insertion cannula. The analyte sensor is at least partially placed inside the insertion cannula.
B · US 2019/0021636 A1 · ¶ 20
1.3a removable sterility cap that at least partially surrounds the insertable portion; and
In order to achieve sterility nevertheless, sterile plastic or rubber covers, so-called sterile barriers, are generally pulled over the (inherently non-sterile) device, or are used to give the device a sterile covering.
A · US 2018/0325616 A1 · ¶ 4
The sealed compartment comprises at least one detachable upper cap and at least one detachable lower cap. The detachable lower cap is configured for detachment before insertion, thereby opening the insertable portion for insertion.
B · US 2019/0021636 A1 · ¶ 20
1.4a housing, comprising: an open channel at least partially surrounding the analyte sensor and the insertion component, an electronics compartment with an electronic unit received therein, a lower housing portion and an upper housing portion, and a sealing channel comprising an input filling port and an output filling port, wherein the sealing channel is at least partially filled with a sealing material configured for sealing an interior space enclosed by the upper housing portion and the lower housing portion;
1.5wherein the removable sterility cap, the open channel and the insertion cannula holder form a sterile compartment for the insertion cannula and at least the insertable portion of the analyte sensor.
A sterile barrier assembly includes a tab sliding along a sliding path in a cavity of the sterile barrier assembly and a barrier membrane partitioning the cavity into a sterile side and a non-sterile side.
A · US 2018/0325616 A1 · abstract
The sensor compartment forms a sealed compartment receiving at least the insertable portion of the analyte sensor. The sealed compartment comprises at least one detachable upper cap and at least one detachable lower cap.
B · US 2019/0021636 A1 · ¶ 20

An empty cell means only that no passage was reproduced there.

Statements in these documents
Current sterilization techniques (such as steam sterilizing) are not suitable or only conditionally suitable for electrical and electronic equipment.
A · US 2018/0325616 A1 · ¶ 4
Therefore, there is a need for a sterile barrier assembly that provides for an easier removal and attachment to a surgical instrument.
A · US 2018/0325616 A1 · ¶ 5
The device and methods according to the present invention may mainly be used for long-term monitoring of an analyte concertation in a body fluid, such as for long-term monitoring of a blood glucose level or of the concentration of one or more other types of analytes in a body fluid.
B · US 2019/0021636 A1 · ¶ 1
However, additionally or alternatively, the invention can also be applied to other types of analytes.
B · US 2019/0021636 A1 · ¶ 2
Cite aspatent.fyi, US 2026/0354715 A1, claim 1, first published 2026-11-19T02:47:19-05:00, https://patent.fyi/US20260354715/, SHA-256 efc465fd060b81bee272581c4ca7d8c737346f51c8540e8375d5be9bdbf41cdc
First published
Permanent addresshttps://patent.fyi/US20260354715/
Content fingerprint (SHA-256)efc465fd060b81bee272581c4ca7d8c737346f51c8540e8375d5be9bdbf41cdc
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi